For citations:
Ganyukova N.G., Likstanov M.I., Kosinova M.V., Kushnir I.N., Moses V.G., Moses K.B. Efficiency of il-6 inhibitor (olokizumab) in suppressing inflammation in patients with moderate COVID-19 pneumonia. Fundamental and Clinical Medicine. 2020;5(4):8-13. (In Russ.) https://doi.org/10.23946/2500-0764-2020-5-4-8-13
Email this article 